To define HBsAg-mutations correlated with different serum HBV-DNA levels in HBV chronically-infected drug-naive patients
AbstractDespite the extensive molecular information on serum-derived human hepatitis B viruses (HBV)...
BACKGROUNDS AND AIMS: In chronic hepatitis B virus (HBV) infection, quantitative HBV surface antigen...
Resistance to anti-viral drugs is a global problem in the treatment of HBV. Around 350 million peopl...
To define HBsAg-mutations correlated with different serum HBV-DNA levels in HBV chronically-infected...
Increasing evidences suggest that HBsAg-production varies across HBV-genotypes. HBsAg C-terminus pla...
To investigate the clinical significance and presence of mutations in the surface (S) and overlappin...
AIM: To investigate the clinical significance and presence of mutations in the surface (S) and overl...
Hepatitis B virus (HBV) mutants have recently been identified in patients with acute or fulminant as...
Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B v...
Hepatitis B virus (HBV) mutants have recently been identified in patients with acute or fulminant as...
Objective To analyze antigenicity of N-glycosylation mutations in the major hydrophilic region (MHR)...
The prevalence and clinical signi®cance of naturally occurring mutations in the full-length surface ...
BACKGROUND: An impaired HBsAg-secretion can increase HBV oncogenic-properties. Here, we investigate ...
International audienceOccult hepatitis B virus infection (OBI) is a low-level asymptomatic phase of ...
AbstractBackgroundThe mechanism underlying the coexistence of hepatitis B surface antigen and antibo...
AbstractDespite the extensive molecular information on serum-derived human hepatitis B viruses (HBV)...
BACKGROUNDS AND AIMS: In chronic hepatitis B virus (HBV) infection, quantitative HBV surface antigen...
Resistance to anti-viral drugs is a global problem in the treatment of HBV. Around 350 million peopl...
To define HBsAg-mutations correlated with different serum HBV-DNA levels in HBV chronically-infected...
Increasing evidences suggest that HBsAg-production varies across HBV-genotypes. HBsAg C-terminus pla...
To investigate the clinical significance and presence of mutations in the surface (S) and overlappin...
AIM: To investigate the clinical significance and presence of mutations in the surface (S) and overl...
Hepatitis B virus (HBV) mutants have recently been identified in patients with acute or fulminant as...
Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B v...
Hepatitis B virus (HBV) mutants have recently been identified in patients with acute or fulminant as...
Objective To analyze antigenicity of N-glycosylation mutations in the major hydrophilic region (MHR)...
The prevalence and clinical signi®cance of naturally occurring mutations in the full-length surface ...
BACKGROUND: An impaired HBsAg-secretion can increase HBV oncogenic-properties. Here, we investigate ...
International audienceOccult hepatitis B virus infection (OBI) is a low-level asymptomatic phase of ...
AbstractBackgroundThe mechanism underlying the coexistence of hepatitis B surface antigen and antibo...
AbstractDespite the extensive molecular information on serum-derived human hepatitis B viruses (HBV)...
BACKGROUNDS AND AIMS: In chronic hepatitis B virus (HBV) infection, quantitative HBV surface antigen...
Resistance to anti-viral drugs is a global problem in the treatment of HBV. Around 350 million peopl...